Jatin Shah - Jul 12, 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
EVP, Chief Medical Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Jatin Shah
Stock symbol
KPTI
Transactions as of
Jul 12, 2021
Transactions value $
-$6,470
Form type
4
Date filed
7/13/2021, 06:21 PM
Previous filing
May 11, 2021
Next filing
Feb 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Tax liability -$6.47K -665 -0.5% $9.73* 131K Jul 12, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021.